1 |
Akhavan A, Binesh F, Heidari S (2014). Survival of brain metastatic patients in Yazd, Iran. Asian Pac J Cancer Prev, 15, 3571-4.
DOI
|
2 |
Cai Y, Wang JY, Liu H (2013). Clinical observation of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in Non-small cell lung cancer patients with chemotherapy failure. Asian Pac J Cancer Prev, 14 (10), 5699-703.
DOI
ScienceOn
|
3 |
Delattre JY, Krol G, Thaler HT, et al (1988). Distribution of brain metastases. Arch Neurol, 45, 741‑4.
DOI
|
4 |
Duan L, Zeng R, Yang KH, et al (2014). Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastasis: a Meta-analysis. Asian Pac J Cancer Prev, 15, 911-5.
DOI
ScienceOn
|
5 |
Erten C, Demir L, Somali I, et al (2013). Cisplatin plus Gemcitabine for treatment of breast cancer patients with brain metastasis; a preferential option for triple negative patients? Asian Pac J Cancer Prev, 14, 3711-7.
DOI
|
6 |
Fabi A, Felici A, Metro G, et al (2011). Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center. J Exp Clin Cancer Res, 30, 10.
DOI
|
7 |
Fang H, Lin RY, Sun MX, et al (2014). Efficacy and survivalassociated factors with geftinib combined with cisplatin and gemcitabine for advanced non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 10967-70.
|
8 |
Gaspar L, Scott C, Rotman M, et al (1997). Recursive partitioning analsis (RPA) of prognostic factors in three radiation therapy oncology group (rtog) brain metastases trials. Int J Radiat Oncol Biol Phys, 37, 745-51.
DOI
|
9 |
Jin J, Zhou X, Liang X, et al (2011). A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population. J Neurooncol, 103, 649-55.
DOI
|
10 |
Johnson JD, Young B (1996). Demographics of brain metastasis. Neurosurg Clin N Am, 7, 337-44.
|
11 |
Lagerwaard FJ, Levendag PC, Nowak PJ, et al (1999). Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys, 43, 795-803.
DOI
|
12 |
Liu WJ, Zeng XT, Qin HF, et al (2012). Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: A meta-analysis of 19 randomized controlled Trials. Asian Pac J Cancer Prev, 13, 3253-8.
DOI
ScienceOn
|
13 |
Miabi Z (2011). Metastatic brain tumors: a retrospective review in East Azarbyjan (Tabriz). Acta Med Iran, 49, 115-7.
|
14 |
Saha A, Ghosh SK, Roy C, et al (2013). Demographic and clinical profile of patients with brain metastases: A retrospective study. Asian J Neurosurg, 8, 157-61.
DOI
ScienceOn
|
15 |
Sawaya R, Ligon BL, Bindal RK (1994). Management of metastatic brain tumors. Ann Surg Oncol, 1, 169-78.
DOI
|
16 |
Yanamoto M, Serizawa T, Shuto T, et al (2014). Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol, 15, 387-95.
DOI
|
17 |
Song WG, Wang YF, Wang RL, et al (2013). Therapeutic regimens and prognostic factors of brain metastatic cancers. Asian Pac J Cancer Prev, 14, 923-7.
DOI
ScienceOn
|
18 |
Subramanian A, Harris A, Piggott K, et al (2002). Metastasis to and from the central nervous system: The 'relatively protected site'. Lancet Oncol, 3, 498‑507.
DOI
|